156 related articles for article (PubMed ID: 7586705)
1. Augmented endogenous nitric oxide production in partial portal vein-ligated rats.
Hori N; Takahashi H; Okanoue T; Sawa Y; Mori T; Takami S; Yoshimura M; Kashima K
Clin Exp Pharmacol Physiol; 1995 Aug; 22(8):506-11. PubMed ID: 7586705
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
Dig Dis Sci; 1993 Dec; 38(12):2195-202. PubMed ID: 8261820
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension.
Pizcueta MP; Piqué JM; Bosch J; Whittle BJ; Moncada S
Br J Pharmacol; 1992 Jan; 105(1):184-90. PubMed ID: 1596680
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.
Kravetz D; Bosch J; Arderiu M; Pilar Pizcueta M; Rodés J
Hepatology; 1989 Jun; 9(6):808-14. PubMed ID: 2714733
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
10. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
[TBL] [Abstract][Full Text] [Related]
12. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
Van de Casteele M; Hösli M; Sägesser H; Reichen J
J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
14. Effect of portacaval surgical anastomosis on systemic and splanchnic hemodynamics in portal hypertensive, cirrhotic rats.
Romeo JM; López-Farré A; Martín-Paredero V; López-Novoa JM
Can J Physiol Pharmacol; 1988 Dec; 66(12):1493-8. PubMed ID: 3228783
[TBL] [Abstract][Full Text] [Related]
15. Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats.
Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
Eur J Clin Invest; 2004 Apr; 34(4):290-6. PubMed ID: 15086361
[TBL] [Abstract][Full Text] [Related]
16. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
[TBL] [Abstract][Full Text] [Related]
17. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
Wang CT; Kuang YL; Chen ZP
Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
[TBL] [Abstract][Full Text] [Related]
18. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension.
Pilette C; Moreau R; Sogni P; Kirstetter P; Cailmail S; Pussard E; Lebrec D
Eur J Pharmacol; 1996 Sep; 312(1):63-8. PubMed ID: 8891579
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
